These emerging drugs , including Wegovy, Mounjaro , and Retatrutide , represent a significant advancement in addressing type 2 the condition and assisting with weight loss . They function by mimicking the body’s natural peptide GLP-1 , assisting to moderate blood levels and reduce hunger . The medication has somewhat distinct characteristics and